TY - JOUR
T1 - Epidemiological modelling in refugee and internally displaced people settlements
T2 - challenges and ways forward
AU - Aylett-Bullock, Joseph
AU - Gilman, Robert Tucker
AU - Hall, Ian
AU - Kennedy, David
AU - Evers, Egmond Samir
AU - Katta, Anjali
AU - Ahmed, Hussien
AU - Fong, Kevin
AU - Adib, Keyrellous
AU - Al Ariqi, Lubna
AU - Ardalan, Ali
AU - Nabeth, Pierre
AU - von Harbou, Kai
AU - Hoffmann Pham, Katherine
AU - Cuesta-Lazaro, Carolina
AU - Quera-Bofarull, Arnau
AU - Gidraf Kahindo Maina, Allen
AU - Valentijn, Tinka
AU - Harlass, Sandra
AU - Krauss, Frank
AU - Huang, Chao
AU - Moreno Jimenez, Rebeca
AU - Comes, Tina
AU - Gaanderse, Mariken
AU - Milano, Leonardo
AU - Luengo-Oroz, Miguel
N1 - data source: No data was collected or analysed
PY - 2022/3/9
Y1 - 2022/3/9
N2 - The spread of infectious diseases such as COVID-19 presents many challenges to healthcare systems and infrastructures across the world, exacerbating inequalities and leaving the world's most vulnerable populations at risk. Epidemiological modelling is vital to guiding evidence-informed or data-driven decision making. In forced displacement contexts, and in particular refugee and internally displaced people (IDP) settlements, it meets several challenges including data availability and quality, the applicability of existing models to those contexts, the accurate modelling of cultural differences or specificities of those operational settings, the communication of results and uncertainties, as well as the alignment of strategic goals between diverse partners in complex situations. In this paper, we systematically review the limited epidemiological modelling work applied to refugee and IDP settlements so far, and discuss challenges and identify lessons learnt from the process. With the likelihood of disease outbreaks expected to increase in the future as more people are displaced due to conflict and climate change, we call for the development of more approaches and models specifically designed to include the unique features and populations of refugee and IDP settlements. To strengthen collaboration between the modelling and the humanitarian public health communities, we propose a roadmap to encourage the development of systems and frameworks to share needs, build tools and coordinate responses in an efficient and scalable manner, both for this pandemic and for future outbreaks.
AB - The spread of infectious diseases such as COVID-19 presents many challenges to healthcare systems and infrastructures across the world, exacerbating inequalities and leaving the world's most vulnerable populations at risk. Epidemiological modelling is vital to guiding evidence-informed or data-driven decision making. In forced displacement contexts, and in particular refugee and internally displaced people (IDP) settlements, it meets several challenges including data availability and quality, the applicability of existing models to those contexts, the accurate modelling of cultural differences or specificities of those operational settings, the communication of results and uncertainties, as well as the alignment of strategic goals between diverse partners in complex situations. In this paper, we systematically review the limited epidemiological modelling work applied to refugee and IDP settlements so far, and discuss challenges and identify lessons learnt from the process. With the likelihood of disease outbreaks expected to increase in the future as more people are displaced due to conflict and climate change, we call for the development of more approaches and models specifically designed to include the unique features and populations of refugee and IDP settlements. To strengthen collaboration between the modelling and the humanitarian public health communities, we propose a roadmap to encourage the development of systems and frameworks to share needs, build tools and coordinate responses in an efficient and scalable manner, both for this pandemic and for future outbreaks.
KW - epidemiology
KW - mathematical modelling
KW - COVID-19
KW - SPREAD
KW - DYNAMICS
U2 - 10.1136/bmjgh-2021-007822
DO - 10.1136/bmjgh-2021-007822
M3 - Article
C2 - 35264317
SN - 2059-7908
VL - 7
JO - BMJ Global Health
JF - BMJ Global Health
IS - 3
M1 - e007822
ER -